This federal contract award is for the delivery of Envarsus XR 1 mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,677.52 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 27, 2024.
The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Generated 3/6/25, 9:53 AM